It is provided herein a method of treating an Autism Spectrum Disorder (ASD) in a patient by administering to the patient a therapeutically effective amount of a composition of a compound that is a positive allosteric modulator of the GABAA receptor having a selectivity towards an α1 subunit of the receptor.
Treatment of autism and autism spectrum disorders (ASD)